Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Schreier A, Zappasodi R, Serganova I, Brown KA, Demaria S, Andreopoulou E. Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer. Front Oncol. 2022;12:1061789.

Yuen CA, Hsu J-, Van Besien K, Reshef R, Iwamoto FM, Haggiagi A, et al. Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience. J Immunother. 2022;45(5):254-262.

de Leval L, Alizadeh AA, P Bergsagel L, Campo E, Davies A, Dogan A, et al. Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. 2022;140(21):2193-2227.

Xia Y, Inoue K, Du Y, Baker SJ, E Reddy P, Greenblatt MB, et al. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis. Nat Commun. 2022;13(1):3920.

Oh C-, Dolatabadi N, Cieplak P, Diaz-Meco MT, Moscat J, Nolan JP, et al. S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia. J Neurosci. 2022;42(14):3011-3024.

Hanel W, Lata P, Youssef Y, Tran H, Tsyba L, Sehgal L, et al. A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells. Exp Hematol Oncol. 2022;11(1):40.

Rivera-Cruz G, Boyraz B, Petrozza JC. Reply of the Authors: The Waldo of fibroids under the microscope: fumarate hydratase-deficient leiomyomata. F S Rep. 2022;3(2):174.

Young A, Bu W, Jiang W, Ku A, Kapali J, Dhamne S, et al. Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer. Cancer Prev Res (Phila). 2022;15(1):3-10.

Lubetzky M, Zhao Z, Sukhu A, Sharma V, Sultan S, Kapur Z, et al. Characteristics of natural immunity to SARS-CoV-2 over time in wait-listed dialysis patients and recent kidney transplant recipients. Nephrol Dial Transplant. 2022;37(8):1585-1587.

Rodino KG, Peaper DR, Kelly BJ, Bushman F, Marques A, Adhikari H, et al. Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1. medRxiv. 2022.